Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
inhalational analgesic
|
| gptkbp:activeIngredient |
methoxyflurane
|
| gptkbp:approvedBy |
gptkb:Australia
gptkb:Belgium gptkb:France gptkb:Ireland gptkb:New_Zealand gptkb:United_Kingdom |
| gptkbp:ATCCode |
N02BG07
|
| gptkbp:contraindication |
renal impairment
hypersensitivity to methoxyflurane |
| gptkbp:countryOfOrigin |
gptkb:Australia
|
| gptkbp:discoveredBy |
1960s
|
| gptkbp:duration |
short
|
| gptkbp:form |
gptkb:water
inhaler |
| https://www.w3.org/2000/01/rdf-schema#label |
Penthrox
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Medical Developments International
|
| gptkbp:marketedAs |
1970s
|
| gptkbp:notRecommendedFor |
children under 5 years
|
| gptkbp:onset |
gptkb:fire
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness |
| gptkbp:usedFor |
pain relief
|
| gptkbp:usedIn |
emergency medicine
ambulance services minor surgical procedures |
| gptkbp:bfsParent |
gptkb:Mundipharma_Distribution_GmbH
gptkb:Mundipharma_International_Limited |
| gptkbp:bfsLayer |
8
|